Cargando…

Risk Factors for Ifosfamide-Related Encephalopathy in Adult Cancer Patients: An Integrative Review

Patients receiving ifosfamide as part of their cancer treatment are at risk for ifosfamide-related encephalopathy (IRE), a potentially serious adverse event affecting up to 60% of patients. Symptoms range from transient altered mental status to coma and death. Consensus regarding risk factors for th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee Brink, Amanda, Bowe, Christi, Dains, Joyce E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Harborside Press LLC 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863121/ https://www.ncbi.nlm.nih.gov/pubmed/33604097 http://dx.doi.org/10.6004/jadpro.2020.11.4.4

Ejemplares similares

The Impact of Peripheral Cooling on Chemotherapy-Induced Peripheral Neuropathy: An Integrative Review
por: Sphar, Bethany G., et al.
Publicado: (2020)

Early Detection of Vulvovaginal Graft-Versus-Host Disease: An Integrative Review
por: Ten Hagen, Payton L., et al.
Publicado: (2021)

Telehealth Interventions for Supportive Management and Early Recognition of Treatment-Related Symptoms in Patients With Hematologic Malignancies
por: Yajima, Chasity, et al.
Publicado: (2021)

Antibiotic Therapy and Gastrointestinal Graft-Versus-Host Disease in the Allogeneic Stem Cell Transplantation Population
por: Thomas, Jessica, et al.
Publicado: (2022)

Two Cases of Fatal Encephalopathy Related to Ifosfamide: An Adverse Role of Aprepitant?
por: Séjourné, Alice, et al.
Publicado: (2014)

Quality of Life in Adult Cancer Patients With Underage Children: An Integrative Review
por: Mota-George, Gabriela, et al.
Publicado: (2023)

Ifosfamide nephrotoxicity in adult patients
por: Ensergueix, Gaël, et al.
Publicado: (2019)

Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature
por: Pelgrims, J, et al.
Publicado: (2000)

Ifosfamide-Induced Encephalopathy Successfully Prevented by Methylene Blue: A Pediatric Case Report and Review of the Literature
por: Furui, Yu, et al.
Publicado: (2023)

Fatal Ifosfamide-Induced Metabolic Encephalopathy in Patients with Recurrent Epithelial Ovarian Cancer: Report of Two Cases
por: Shin, You-Jung, et al.
Publicado: (2011)

Ifosfamide-induced Encephalopathy Precipitated by Aprepitant: A Rarely Manifested Side Effect of Drug Interaction
por: Kataria, Pritam Sureshchandra, et al.
Publicado: (2017)

The growing pains of ifosfamide
por: Sprangers, Ben, et al.
Publicado: (2020)

Ifosfamide-Induced Metabolic Encephalopathy in 2 Patients With Cutaneous T-Cell Lymphoma Successfully Treated With Methylene Blue
por: Vakiti, Anusha, et al.
Publicado: (2018)

A novel case of prolonged Ifosfamide encephalopathy and long-term treatment with methylene blue: a case report and review of literature
por: Chain, Gabriel, et al.
Publicado: (2022)

Single-Centre Experience of Systemic Treatment with Vincristine, Ifosfamide, and Doxorubicin Alternating with Etoposide, Ifosfamide, and Cisplatin in Adult Patients with Ewing Sarcoma
por: Requilé, Annelies, et al.
Publicado: (2017)

Adverse Effects of Virus-Specific T-Cell Therapy: An Integrative Review
por: Simmons, Heidi Z., et al.
Publicado: (2019)

Effectiveness of Granulocyte Transfusions in Neutropenic Adult Oncology Patients: A Comprehensive Review of the Literature
por: Demla, Asha, et al.
Publicado: (2016)

Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancy
por: Miller, Devon, et al.
Publicado: (2022)

Evaluation of Dose-Intense Ifosfamide, with and Without Edatrexate, in Adults with Sarcoma
por: Casper, Ephraim S., et al.
Publicado: (1999)

Ifosfamide-induced encephalopathy: the EEG with frontal intermittent delta activity, and rapid resolution with methylene blue: A case report
por: Hamilton, Juliette E., et al.
Publicado: (2020)

Ultrasound Evaluation of Carotid Artery Intima-Media Thickness: Effective Early Marker of Carotid Artery Disease in Adult Head and Neck Cancer Patients After Neck Radiation?
por: Randolph, Whitney, et al.
Publicado: (2022)

Hormone Replacement Therapy: An Increased Risk of Recurrence and Mortality for Breast Cancer Patients?
por: Lupo, Molly, et al.
Publicado: (2015)

Pharmacokinetic Study of Perioperative Intravenous Ifosfamide
por: Van der Speeten, Kurt, et al.
Publicado: (2011)

The interaction of ifosfamide and aprepitant in gynecologic malignancies()
por: Shindorf, Mackenzie L., et al.
Publicado: (2013)

Ifosfamide-Induced Malignancy of Ureter and Bladder
por: Sannu, Aparna, et al.
Publicado: (2017)

Partial Fanconi Syndrome Induced by Ifosfamide
por: Das, Sulagna, et al.
Publicado: (2019)

Ifosfamide as a Cause of Fanconi Syndrome
por: Martinez, Daniel, et al.
Publicado: (2022)

Pharmacokinetics and metabolism of ifosfamide in relation to DNA damage assessed by the COMET assay in children with cancer
por: Willits, I, et al.
Publicado: (2005)

Neoadjuvant and adjuvant chemotherapy with doxorubicin and ifosfamide for bone sarcomas in adult and older patients
por: URAKAWA, HIROSHI, et al.
Publicado: (2014)

Predictors of Cervical Cancer Screening Adherence in the United States: A Systematic Review
por: Limmer, Karen, et al.
Publicado: (2014)

Possible metabolic interaction between docetaxel and ifosfamide
por: Ando, Y
Publicado: (2000)

The influence of ifosfamide scheduling on acute nephrotoxicity in children.
por: English, M. W., et al.
Publicado: (1997)

Effect of Glutathione Depletion on Ifosfamide Nephrotoxicity in Rats
por: Garimella-Krovi, Sudha, et al.
Publicado: (2008)

Ifosfamide-induced Fanconi syndrome with diabetes insipidus
por: Leem, Ah Young, et al.
Publicado: (2014)

Karyomegalic interstitial nephropathy following ifosfamide therapy
por: Jayasurya, R., et al.
Publicado: (2016)

Reversible Encepahlopathy Induced by Ifosfamide with Brain Imaging
por: Ali Mohamed, Daoud, et al.
Publicado: (2021)

Osteomalacia as a Late Metabolic Complication of Ifosfamide Chemotherapy in Young Adults: Illustrative Cases and Review of the Literature
por: Church, D. N., et al.
Publicado: (2007)

Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study
por: Skinner, R, et al.
Publicado: (2000)

Phase I study of docetaxel plus ifosfamide in patients with advanced cancer
por: Marx, G, et al.
Publicado: (2002)

OTHR-16. CONCURRENT USE OF APREPITANT AND IFOSFAMIDE IN PEDIATRIC CANCER PATIENTS
por: Winzent, Shelby, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_294odq6nlni5hvfv16ughpjn8q